Alpa Laboratories (ALPA) | Stock Overview & Key Data
Alpa Laboratories Performance Comparison
Stock Range
Today's Range
Low: ₹103.01
High: ₹104.55
on July 21, 2025
52 Week Range
Low: ₹86.31
High: ₹144.50
on July 23, 2024
on September 30, 2024
All-Time High: ₹144.50 on September 30, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR2.2B
EPS
9.34
P/E Ratio (TTM)
11.10
Forward P/E
19.60
P/B Ratio
1.35
PEG Ratio
19.60
Div. Yield
N/A
ROE
12.06%
Beta
0.691
Debt to Equity
0.00
Financial Highlights
Profitability
Gross Margin
26.95%
Operating Margin
-0.96%
Profit Margin
17.34%
Returns and Earnings
Return on Assets (TTM)
0.79%
Return on Equity (TTM)
12.06%
EBITDA
INR281.5M
Net Income (TTM)
INR195.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR53.45
Quarterly Revenue Growth (YoY)
69.10%
Quarterly Earnings Growth (YoY)
75.19%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Alpa Laboratories ALPA | 2.18B Small-cap | -0.10% | 5.17% | -5.84% | -19.70% | -16.61% | 16.88% | 68.59% | 403.30% |
| Sun Pharmaceutical SUNPHARMA | 4.06T Large-cap | 1.29% | 2.77% | -2.94% | -4.76% | -10.39% | 7.97% | 93.66% | 248.76% |
| Divi's Laboratories DIVISLAB | 1.81T Large-cap | -1.51% | 2.79% | 14.26% | 12.18% | 10.84% | 48.93% | 77.30% | 186.56% |
| Aarti Drugs AARTIDRUGS | 47.75B Small-cap | 10.47% | 17.20% | 44.67% | 22.86% | 14.86% | 1.96% | 21.56% | 31.91% |
| Sequent Scientific SEQUENT | 46.95B Small-cap | 1.92% | -3.15% | 26.78% | 3.51% | 1.73% | 33.30% | 62.99% | 62.92% |
| Unichem Laboratories UNICHEMLAB | 44.19B Small-cap | 6.24% | 9.34% | -0.98% | -11.88% | -14.65% | 20.65% | 108.47% | 199.76% |
Ownership & Short Interest
Insider Ownership
57.29%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
18K
Average 90-Day Volume
28K
Alpa Laboratories Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Alpa Laboratories would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ALPA's 52-week high and low?
- In the last 52 weeks, Alpa Laboratories reached a high of ₹144.50 (on September 30, 2024) and a low of ₹86.31 (on July 23, 2024).
- What is the market cap and P/E ratio for ALPA?
- Curious about Alpa Laboratories's size and valuation? Its market capitalization stands at 2.18B. When it comes to valuation, the P/E ratio (trailing twelve months) is 11.10, and the forward P/E (looking ahead) is 19.60.
- Does ALPA pay dividends? If so, what's the yield?
- As for dividends, Alpa Laboratories isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Alpa Laboratories's main competitors or similar companies to consider before investing?
When looking at Alpa Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA4.06T Healthcare Drug Manufacturers - Specialty & Generic 7.97% 93.66% Divi's Laboratories
DIVISLAB1.81T Healthcare Drug Manufacturers - Specialty & Generic 48.93% 77.30% Aarti Drugs
AARTIDRUGS47.75B Healthcare Drug Manufacturers - Specialty & Generic 1.96% 21.56% Sequent Scientific
SEQUENT46.95B Healthcare Drug Manufacturers - Specialty & Generic 33.30% 62.99% Unichem Laboratories
UNICHEMLAB44.19B Healthcare Drug Manufacturers - Specialty & Generic 20.65% 108.47% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Alpa Laboratories Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Alpa Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.06%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at 26.95%.
- What is the recent revenue and earnings growth for ALPA?
- Looking at Alpa Laboratories's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 69.10%, and quarterly earnings saw a YoY growth of 75.19%.
- How much of ALPA stock is held by insiders and institutions?
- Wondering who owns Alpa Laboratories stock? Company insiders (like executives and directors) hold about 57.29% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.